1-8 of 8
Zhaoyu Sun
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO3-06-09: A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer

David Page, Alexander Hall, Krystle Collins, Nicole Moxon, Staci Mellinger, Tracy Kelly, Aysha Kelley, Nicole Fredrich, Amanda Seino, Gabriella Liberatore, Alison Conlin, Zheng Topp, Kelly Perlewitz, Sasha Stanton, Walter Urba, Yaping Wu, Maritza Martel, Zhaoyu Sun, Yoshinobu Kogushi, William Redmond, Tiffany Traina, Ayca Guculp
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-06-09.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-06-09
Published: 02 May 2024
View article titled, Abstract PO3-06-09: A phase II study of nivolumab plus ipilimumab and androgen receptor antagonist bicalutamide to stimulate thymic T cell generation in HER2-negative metastatic breast cancer
Journal Articles

Abstract PO2-03-10: Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial

David Page, Alan Su, Nicole Moxon, Staci Mellinger, Tracy Kelly, Nicole Fredrich, Amanda Seino, Zheng Topp, Philippa Newell, Kristen Massimino, Shaghayegh Aliabadi, Yaping Wu, Maritza Martel, William Redmond, Yoshinobu Kogushi, Grace Mcgee, Alejandra Mendez-Torres, Zhaoyu Sun, James Imatani, Alison Conlin, Kelly Perlewitz, Tyler Nielsen, Sasha Stanton
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-03-10.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-03-10
Published: 02 May 2024
View article titled, Abstract PO2-03-10: Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial
Journal Articles

Abstract OT1-18-03: The neoIRX trial:locoregional cytokine therapy to promote immunologic priming and enhanced response to neoadjuvant pembrolizumab plus chemotherapy in triple negative breast cancer (TNBC)

Katherine Sanchez, Alison Conlin, Parvin Peddi, Sasha Stanton, Janet Ruzich, Kelly Perlewitz, Yaping Wu, Nicole Moxon, Staci Mellinger, Zhaoyu Sun, William Redmond, David B Page
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-18-03.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-18-03
Published: 15 February 2022
View article titled, Abstract OT1-18-03: The neoIRX trial:locoregional cytokine therapy to promote immunologic priming and enhanced response to neoadjuvant pembrolizumab plus chemotherapy in triple negative breast cancer (TNBC)
Journal Articles

Abstract OT1-18-04: A phase II study of dual immune checkpoint blockade (ICB) plus bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC)

David B Page, Krystle L Collins, Brie Chun, Zhaoyu Sun, William L Redmond, Maritza Martel, Yaping Wu, Nicole Moxon, Staci L Mellinger, Walter J Urba, Tiffany A Traina, Ayca Gucalp
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-18-04.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-18-04
Published: 15 February 2022
View article titled, Abstract OT1-18-04: A phase II study of dual immune checkpoint blockade (ICB) plus bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC)
Journal Articles

Abstract 1665: QuPath versus InForm: Digital image analysis of multiplex immunofluorescence (mIF) tumor-infiltrating lymphocyte (TIL) outcomes in an immunotherapy clinical trial

Benjamin M. Nikitin, Brie Chun, Isaac Kim, William L. Redmond, Katherine Sanchez, Zhaoyu Sun, Yaping Wu, David B. Page
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1665.
https://doi.org/10.1158/1538-7445.AM2021-1665
Published: 01 July 2021
View article titled, Abstract 1665: QuPath versus InForm: Digital image analysis of multiplex immunofluorescence (mIF) tumor-infiltrating lymphocyte (TIL) outcomes in an immunotherapy clinical trial
Journal Articles

Abstract P6-10-09: Multispectral immunofluorescence (mIF) to detect dynamic changes in PD-L1 expression, immune cell (IC) infiltration, and tumor-IC interactions in primary breast cancer (BC) immuno-oncology (I-O) clinical trials

Katherine Sanchez, Isaac Kim, ShuChing Chang, Maritza Martel, Yaping Wu, Brady Bernard, Joanna Pucilowska, Zhaoyu Sun, William Redmond, Dottie Waddell, Walter Urba, David B Page
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-10-09.
https://doi.org/10.1158/1538-7445.SABCS19-P6-10-09
Published: 15 February 2020
View article titled, Abstract P6-10-09: Multispectral immunofluorescence (mIF) to detect dynamic changes in PD-L1 expression, immune cell (IC) infiltration, and tumor-IC interactions in primary breast cancer (BC) immuno-oncology (I-O) clinical trials
Journal Articles

Abstract 2706: Comprehensive immune profiling of primary tumor-infiltrating lymphocytes isolated from primary non-small cell lung cancer specimens

Yoshinobu Koguchi, William Miller, Brian D. Piening, Venkatesh Rajamanickam, Brady Bernard, Zhaoyu Sun, Yaping Wu, Johanna K. Kaufmann, William L. Redmond
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2706.
https://doi.org/10.1158/1538-7445.AM2019-2706
Published: 01 July 2019
View article titled, Abstract 2706: Comprehensive immune profiling of primary tumor-infiltrating lymphocytes isolated from primary non-small cell lung cancer specimens
Journal Articles

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Jason R. Baird, R. Bryan Bell, Victoria Troesch, David Friedman, Shelly Bambina, Gwen Kramer, Tiffany C. Blair, Terry Medler, Yaping Wu, Zhaoyu Sun, Tanja D. de Gruijl, Rieneke van de Ven, Rom S. Leidner, Marka R. Crittenden, Michael J. Gough
Journal: Cancer Research
Cancer Res (2018) 78 (21): 6308–6319.
https://doi.org/10.1158/0008-5472.CAN-18-1652
Published: 01 November 2018
View article titled, Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma
Open the PDF for Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data